Identification and efficacy of longitudinal markers for survival
From MaRDI portal
Recommendations
- Using Frailty Models to Identify the Longitudinal Biomarkers in Survival Analysis
- The method to identify a biomarker and to evaluate its efficiency for survival by using the joint model of the accelerate failure time and longitudinal data
- The identification of potential longitudinal biomarkers and measurements of effectiveness for biomarkers as surrogates in multivariate survival data
- Identification of longitudinal biomarkers for survival by a score test derived from a joint model of longitudinal and competing risks data
- Evaluation of longitudinal surrogate markers
Cited in
(31)- Intermediate clinical events, surrogate markers and survival
- Penalised logistic regression and dynamic prediction for discrete-time recurrent event data
- Identification of potential longitudinal biomarkers under the accelerated failure time model in multivariate survival data
- The method to identify a biomarker and to evaluate its efficiency for survival by using the joint model of the accelerate failure time and longitudinal data
- Using the Score Test to Identify the Longitudinal Biomarker Considering Accelerate Failure Time Model with the Frailty in Survival Analysis
- Choice of prognostic estimators in joint models by estimating differences of expected conditional Kullback-Leibler risks
- The identification of potential longitudinal biomarkers and measurements of effectiveness for biomarkers as surrogates in multivariate survival data
- Identification of longitudinal biomarkers in survival analysis for competing risks data
- Identification of longitudinal biomarkers for survival by a score test derived from a joint model of longitudinal and competing risks data
- Using Frailty Models to Identify the Longitudinal Biomarkers in Survival Analysis
- Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach
- Diagnostics for Joint Longitudinal and Dropout Time Modeling
- Explained variation for recurrent event data
- Quantifying and comparing dynamic predictive accuracy of joint models for longitudinal marker and time‐to‐event in presence of censoring and competing risks
- Quantifying the Predictive Performance of Prognostic Models for Censored Survival Data with Time-Dependent Covariates
- Nonparametric two-sample tests of longitudinal data with termination events
- How the mechanism of missing data on longitudinal biomarkers influences the survival analysis
- Bayesian parametric accelerated failure time spatial model and its application to prostate cancer
- Application of trajectories from growth curve in identification of longitudinal biomarker for the multivariate survival data
- Measures of prediction error for survival data with longitudinal covariates
- Dynamic Prediction by Landmarking in Event History Analysis
- Prospective Accuracy for Longitudinal Markers
- Evaluation of longitudinal surrogate markers
- Joint models for longitudinal and discrete survival data in credit scoring
- Joint models of multivariate longitudinal outcomes and discrete survival data with INLA: an application to credit repayment behaviour
- Optimizing dynamic predictions from joint models using super learning
- Joint models for longitudinal and time-to-event data in a case-cohort design
- Incorporating longitudinal biomarkers for dynamic risk prediction in the era of big data: a pseudo-observation approach
- Optimizing personalized screening intervals for clinical biomarkers using extended joint models
- Robust evaluation of longitudinal surrogate markers with censored data
- A comparison of alternative approaches to dynamic predictions: An application on a short follow-up cohort of patients with Chagas disease
This page was built for publication: Identification and efficacy of longitudinal markers for survival
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5701126)